Population and target considerations for triple-negative breast cancer clinical trials

Author: Hyslop Terry   Michael Yvonne   Avery Tiffany   Rui Hallgeir  

Publisher: Future Medicine

ISSN: 1752-0363

Source: Biomarkers in Medicine, Vol.7, Iss.1, 2013-02, pp. : 11-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract